Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea (OSA), today announced the close of $80 million in Series A funding. The company is developing an easy-to ...

REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea (OSA), today announced the close of $80 million in Series ...

REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea (OSA), today announced the close of $80 million in Series ...

Mosanna is pioneering a pharmaceutical solution for sleep apnea patients with MOS118, a nasal spray administered at bedtime that helps restore the body's natural airway reflex.

EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Mosanna Therapeutics ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland, is ...

Even mild sleep apnea can cause you to stop breathing several times an hour—setting off a cascade of threats to your brain and heart health. SCIENCE; The toll that sleep apnea takes on the body.

Obstructive sleep apnea (OSA) is a common disorder where the airway repeatedly becomes blocked during sleep, causing breathing pauses. This leads to poor sleep quality, daytime fatigue, and ...

EQT Life Sciences Leads USD 80 Million Series A Funding Round In Mosanna Therapeutics To Advance Sleep Apnea Nasal Spray. Date. 2025-06-09 11:01:19. Share on Facebook; Tweet on Twitter ...

Series A Funding will be used to advance Mosanna's nasal spray therapy through Phase 2 Clinical Trials Biotech veteran David Weber has been appointed CEO to lead the company through clinical ...

EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Mosanna Therapeutics ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland, is developing ...

People who have obstructive sleep apnea may have an increased risk of dementia if left untreated, according to a new study of UK electronic health care records. The study, published in BMJ Thorax ...